U.S. Software Stock News

If you’re staring at Cogent Communications Holdings stock and asking yourself what comes next, you’re definitely not alone. After all, this is a company that has provided a wild ride for investors. In just one week, Cogent edged up by 1.3%, while over the past month it’s delivered a much punchier 9.4% gain. Still, when you zoom out, the picture gets trickier: the stock is down a stunning 47.6% year-to-date and has lost 42.3% over the past year. Even stretching the timeline further, the...

If you are navigating the world of real estate investment trusts, chances are you are considering what to do with your Host Hotels & Resorts shares right now. You are not alone—investors across the board have been debating whether this stock is a hidden gem or one that is already reflecting its full potential. Looking at the numbers, Host Hotels & Resorts ended the most recent session at $17.11, and while the stock has dipped by 1.2% over the past week, it is holding steady for the past...

Aris Water Solutions (ARIS) shares have climbed over the past year, returning 45% to investors. The company’s revenue and net income have both improved, and there are clear signals of ongoing business expansion. See our latest analysis for Aris Water Solutions. Momentum for Aris Water Solutions has been steady, with a 1-year total shareholder return of 45% that reflects sustained growth and renewed investor confidence. Recent results suggest that the company’s improving fundamentals are...

On October 2, 2025, AngioDynamics, Inc. reported first quarter earnings, announcing sales of US$75.71 million versus US$67.49 million a year earlier and a reduced net loss of US$10.9 million compared to US$12.8 million in the previous year, alongside basic and diluted loss per share of US$0.26. The company also raised its full fiscal year 2026 sales guidance, now expecting net sales of US$308 million to US$313 million, reflecting a more optimistic outlook on financial and operational...

Thinking about what to do with Jumia Technologies stock? You’re not alone. Lately, this once-under-the-radar e-commerce player has been turning heads with some impressive price movement. The stock jumped 7.1% just over the last week, surged 48.7% in the past month, and is up an astonishing 206.9% year-to-date. Long-term holders have also seen benefits, with gains of 115.3% in the past year and 98.2% over three years. Even the five-year return, a solid 13.8%, suggests resilience despite all...

Trying to decide what to do with Caris Life Sciences stock? You are not alone. With biotech on investors’ minds and volatility ever-present, a confident approach matters more than ever. Over the past month, Caris Life Sciences shares have slipped 18.7%, but that drawdown follows a period of growth, leaving the stock up 6.1% year-to-date. A smaller dip of just 0.1% over the last week hints that the market may be stabilizing after recent headwinds, possibly as investors process shifts in the...

If you are sizing up Webster Financial right now, you are not alone. With the stock closing at $58.96 and boasting a remarkable 132.2% return over five years, many investors are wondering if it is still a smart buy or if the easy money has already been made. While there have been some recent dips, including a 1.4% decline over the past week and 5.3% for the month, the year-to-date gain stands strong at 7.6%, and the one-year return is an impressive 36.5%. These moves suggest that market...

Reitar Logtech Holdings (NasdaqCM:RITR) has made headlines with its newly signed strategic cooperation and investment agreement with NEXX, launching a Smart Fulfillment Center project in Qatar. This move marks Reitar’s entry into the rapidly evolving Middle Eastern logistics sector. See our latest analysis for Reitar Logtech Holdings. Reitar Logtech’s leap into Qatar’s logistics scene comes at a time when its total shareholder return over the past year has dipped slightly by 0.4%. While the...

If you have been watching Verona Pharma’s stock lately, you are probably wondering what to do next. With shares closing at $106.82 in the latest session, it is clear this is a company that has caught serious attention. Just look at the numbers, and you will see why: Verona Pharma is up 121.6% so far this year, and an eye-popping 246.7% over the past twelve months. But the real story goes further back, with staggering multi-year gains. Over the last three years, the stock has jumped 926.1%,...

As major U.S. stock indexes continue to set new records, investors are navigating a landscape that seems to defy the uncertainties of a government shutdown. In such an environment, penny stocks—often representing smaller or newer companies—can offer intriguing opportunities for those looking beyond the market giants. Despite their historically speculative reputation, these stocks can provide a blend of affordability and growth potential when backed by solid financials, making them worthy...

Viant Technology recently announced an expanded partnership with Tubi, Fox Corporation's free ad-supported streaming service, featuring a robust ID sync and deeper ad server integration, which gives advertisers improved reach and accuracy across Tubi's more than 100 million monthly active users and over 300,000 movies and TV episodes. This collaboration brings IRIS.TV's contextual and emotional data technology to Tubi's library, enabling more precise, measurable, and relevant audience...

Algoma Steel Group Inc. recently secured C$500 million in liquidity support from the Canadian and Ontario governments to address ongoing trade challenges and accelerate its business transformation, including a transition to Electric Arc Furnace steelmaking and a focus on the domestic market. This government-backed financing not only provides essential financial flexibility but also signals reinforced public support for Algoma's shift away from blast furnace operations due to U.S. tariffs,...

Wondering whether to add, hold, or walk away from Kilroy Realty? You are not alone. The company's stock has been on something of a rollercoaster, falling 2.7% over the past week, but still up 2.9% for the month and impressively up 18.6% over the last year. Year-to-date performance also sits in positive territory at 5.8%. However, when you zoom out to five years, it is basically flat. What is behind these moves? Like most office-focused real estate companies, Kilroy has had to weather changing...

Slide Insurance Holdings (SLDE) shares pulled back 1% today, giving investors a chance to revisit the company’s core numbers and recent performance. Over the past month, the stock actually climbed 9%. See our latest analysis for Slide Insurance Holdings. Although Slide Insurance Holdings’ share price is still well below its highs for the year, a solid 1-month share price return signals momentum could be shifting in the company’s favor after a tougher stretch earlier in 2024. With investors...

TD SYNNEX (SNX) reported a net profit margin of 1.3%, up slightly from last year’s 1.2%, with earnings growing 13.5% year-over-year. This trails its five-year annual average of 15.2%. Forward-looking projections call for annual earnings growth of 7.6% and revenue growth of 4.5%, suggesting a slower pace compared to the company’s historical performance and the broader US market. With strong profit expansion and no flagged material risks, ongoing revenue and margin growth remain the key drivers...

Wondering what to make of Criteo’s stock after a rocky few months? You are definitely not alone. Whether you are weighing a fresh position or eyeing your existing holdings, the recent numbers grab your attention. Criteo closed at $21.31, but over the last one and three years, shares have dropped a hefty 45.1% and 21.5%, respectively. Even in the past week and month, the slides have continued, with returns of -5.3% and -9.4%. Yet, despite these setbacks, the longer-term five-year return still...

Murano Global Investments (MRNO) has seen its losses accelerate at a striking rate of 99.7% per year over the past five years, with its net profit margin remaining firmly in negative territory. While the stock’s Price-to-Sales Ratio of 3.3x looks cheap compared to peer group averages of 6.9x, it remains slightly above the broader US real estate industry average of 3x. Despite appearing attractively valued on this metric, persistent unprofitability and growing losses present a cautious set of...

Key Insights Getty Images Holdings' estimated fair value is US$1.62 based on 2 Stage Free Cash Flow to Equity Current...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Lionsgate Studios fair value estimate is US$5.26 Lionsgate...

If you are eyeing Vanguard Index Funds - Vanguard S&P 500 ETF and wondering whether now is the time to jump in, you are definitely not alone. The ETF has been grabbing attention as it continues a steady climb, up 1.4% in just the past week, and a robust 4.5% over the last month. Year-to-date, we have seen an impressive 14.5% gain, stacking up to a 19.4% rise over the past year. For long-term holders, it gets even better, with returns over three and five years standing at 87.3% and 109.6%,...

Global Medical REIT (GMRE) just announced a reverse stock split that will convert every five existing shares into one new share and adjust the par value of its common stock. This move is designed to streamline the share structure and is prompting fresh interest from investors curious about what it could mean for GMRE’s future trading dynamics. See our latest analysis for Global Medical REIT. After a relatively quiet year, Global Medical REIT’s reverse split has put the spotlight back on its...

JFB Construction Holdings (NasdaqCM:JFB) grabbed the spotlight after its shares jumped more than 59%, following major new infrastructure contract wins and the announcement of a fresh $43.9 million private placement last week. See our latest analysis for JFB Construction Holdings. JFB Construction’s recent 59% rally stands out against a backdrop of otherwise modest 7-day and year-to-date share price returns. Recent contract wins and a leadership hire have sparked fresh investor optimism. While...

89bio (ETNB) shares have been on the move lately, with investors eyeing recent performance trends and weighing potential growth. The stock posted a 62% gain over the past month, which has turned heads in the biotech sector. See our latest analysis for 89bio. Momentum is definitely building for 89bio, with a strong 1-month share price return of 61.5% and noticeable buzz stemming from recent sector activity. That kind of move stands out even more when you consider the company’s 1-year total...

GreenTree Hospitality Group (NYSE:GHG) reported a net profit margin of 15.3%, a decrease from 16.5% in the previous year. Over the last five years, earnings have declined at an average annual rate of 2.4%, and most recently, the company posted negative earnings growth. Despite challenged margins, the company’s earnings continue to be considered high quality, presenting investors with a nuanced picture this season. See our full analysis for GreenTree Hospitality Group. Next, we will compare...